Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...
Hosted on MSN16d
Texans waive Diontae Johnson after just two games; WR upset after minimal role in wild-card win, per report
The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.
Yardbarker17d
Texans admit defeat on failed Diontae Johnson experiment
More Texans news: Johnson appeared in just two games with Houston and tallied three catches for 24 yards. Considering that the Texans have been without Tank Dell and Stefon Diggs during the back ...
Sports Illustrated17d
Former Carolina Panthers star released by NFL playoff team
The Diontae Johnson experiment did not exactly work out for the Carolina Panthers. It didn't pan out for the Baltimore Ravens, either. And now, the Houston Texans are apparently done with him ...
The Financial Times18d
Johnson & Johnson strikes $14.6bn deal for neuroscience biotech Intra-Cellular
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Johnson & Johnson has struck a $14.6bn deal to buy neuroscience drugmaker Intra-Cellular Therapies ...
Business Insider11d
Johnson & Johnson (JNJ) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) concerning possible violations of federal securities laws. J&J issued a ...